Rituximab Biosimilar - Anti-CD20 Antibody - BSA and Azide free
Description
Recombinant chimeric monoclonal antibody to CD20.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG1
Conjugate
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Flow cytometry analysis with Anti-CD20 Chimeric Antibody [Rituximab Biosimilar] - Azide free (A318931) at 2 µg/ml on Expi293 cells transfected with Human CD20 protein (blue histogram) or Expi293 transfected with irrelevant protein (red histogram). antibody.
Publishing research using Rituximab Biosimilar - Anti-CD20 Antibody - BSA and Azide free (A318931)? Please let us know so that we can list the citation on this page.
Alternative products to Rituximab Biosimilar - Anti-CD20 Antibody - BSA and Azide free (A318931)